flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic disease in the ADA 24: FLOW Trial: Kidney

For example, Rybelsus can cause an allergic reaction or inflammation of the pancreas, kidney or thyroid dysfunction, depression, or apathy

Patients with pre-existing gastrointestinal conditionsinflammatory bowel disease, irritable bowel syndrome, or previous bowel surgeryshould maintain closer monitoring and lower thresholds for seeking medical input, as these populations may experience more pronounced or complex digestive effects

Among the safety events that went uninvestigated, according to the regulator, are two deathsone dated Jan

Semaglutide has transformed weight management for millions, but a common question emerges after successful weight loss: Do I have to take this forever

Since many women of childbearing age may be interested in taking weight-loss drugs, some doctors worry this population doesnt know enough about the potential risks if an unplanned pregnancy were to happen while theyre on the immensely popular medications

Eighteen physician-approved drips, every order reviewed by a board-certified MD and placed by a licensed provider